Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-10
DOI
10.3389/fnagi.2019.00373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safe and sustained expression of human iduronidase after adeno-associated virus 9 intrathecal administration in infant rhesus monkeys
- (2019) Juliette Hordeaux et al. HUMAN GENE THERAPY
- Alzheimer’s disease: future drug development and the blood-brain barrier
- (2019) William M. Pardridge EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
- (2019) Albert M. Maguire et al. OPHTHALMOLOGY
- Adeno-associated virus in the liver: natural history and consequences in tumour development
- (2019) Tiziana La Bella et al. GUT
- Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
- (2019) Darren J. Schofield et al. NEUROBIOLOGY OF DISEASE
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- DNA nanoparticles are safe and nontoxic in non-human primate eyes
- (2018) Ryan A Kelley et al. International Journal of Nanomedicine
- Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery
- (2018) Elias Baghdan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Role of IGF-binding proteins in regulating IGF responses to changes in metabolism
- (2018) David R Clemmons JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats
- (2018) Zhengyu Zhang et al. MOLECULAR PHARMACEUTICS
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Study of Intraventricular Cerliponase Alfa for CLN2 Disease
- (2018) Angela Schulz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
- (2018) Roberto Giugliani et al. Orphanet Journal of Rare Diseases
- Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
- (2018) Zachary Fitzpatrick et al. Molecular Therapy-Methods & Clinical Development
- Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
- (2018) Bernd Bohrmann et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor
- (2018) William M. Pardridge et al. MOLECULAR PHARMACEUTICS
- A Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer’s Disease
- (2018) Rudy Chang et al. MOLECULAR PHARMACEUTICS
- Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy
- (2018) Roselena Silvestri Schuh et al. PHARMACEUTICAL RESEARCH
- Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)
- (2018) Stephen Salloway et al. Alzheimers Research & Therapy
- Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65
- (2018) Eloise Hudry et al. Molecular Therapy-Methods & Clinical Development
- Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?
- (2018) Francesco Panza et al. Immunotherapy
- Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer
- (2018) Dan Wang et al. Molecular Therapy-Methods & Clinical Development
- Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
- (2018) Kousaku Ohno et al. Molecular Therapy-Methods & Clinical Development
- Angiogenesis-targeting microbubbles combined with ultrasound-mediated gene therapy in brain tumors
- (2017) En-Ling Chang et al. JOURNAL OF CONTROLLED RELEASE
- Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial
- (2017) Marc Tardieu et al. LANCET NEUROLOGY
- Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
- (2017) Rudy Chang et al. MOLECULAR PHARMACEUTICS
- Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates
- (2017) Clemens Braun et al. MOLECULAR PHARMACEUTICS
- Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody–Iduronidase Fusion Protein
- (2017) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Biology of GDNF and its receptors — Relevance for disorders of the central nervous system
- (2017) Carlos F. Ibáñez et al. NEUROBIOLOGY OF DISEASE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products
- (2017) Yuan Zhao et al. Human Gene Therapy Methods
- CSF, blood-brain barrier, and brain drug delivery
- (2016) William M. Pardridge Expert Opinion on Drug Delivery
- Preclinical Testing of the Safety and Tolerability of Lentiviral Vector–Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies
- (2016) Ilaria Visigalli et al. HUMAN GENE THERAPY
- Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
- (2016) Syed Faraz Kazim et al. Molecular Neurodegeneration
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Focused Ultrasound Enhances Central Nervous System Delivery of Bevacizumab for Malignant Glioma Treatment
- (2016) Hao-Li Liu et al. RADIOLOGY
- Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo
- (2015) Antonella Mangraviti et al. ACS Nano
- Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study
- (2015) M. Aldenhoven et al. BLOOD
- Blood–brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery
- (2015) William M Pardridge EXPERT OPINION ON THERAPEUTIC TARGETS
- Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood–cerebrospinal fluid barrier in human brain
- (2015) Koichi Matsumoto et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Cationic dendronization of amylose via click chemistry for complexation and transfection of plasmid DNA
- (2015) Kaijin Mai et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy
- (2015) Randy J. Chandler et al. JOURNAL OF CLINICAL INVESTIGATION
- Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics
- (2015) Yoshiyuki Kubo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
- (2015) Jean-Charles Nault et al. NATURE GENETICS
- Targeted delivery of protein and gene medicines through the blood-brain barrier
- (2015) WM Pardridge CLINICAL PHARMACOLOGY & THERAPEUTICS
- Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
- (2014) S.-h. Kan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
- (2014) Darren A. Murrey et al. Human Gene Therapy Clinical Development
- Transport of gabapentin by LAT1 (SLC7A5)
- (2013) David Dickens et al. BIOCHEMICAL PHARMACOLOGY
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
- (2013) S J Gray et al. GENE THERAPY
- Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
- (2013) Yutaro Hoshi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Disaggregation of Amyloid Plaque in Brain of Alzheimer’s Disease Transgenic Mice with Daily Subcutaneous Administration of a Tetravalent Bispecific Antibody That Targets the Transferrin Receptor and the Abeta Amyloid Peptide
- (2013) Rachita K. Sumbria et al. MOLECULAR PHARMACEUTICS
- Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
- (2013) K. Han et al. NEURO-ONCOLOGY
- Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis
- (2013) Diego Cadavid et al. PLoS One
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- (2013) A. Biffi et al. SCIENCE
- Exploiting Endocytosis for Nanomedicines
- (2013) A. Akinc et al. Cold Spring Harbor Perspectives in Biology
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies
- (2012) Qing-Hui Zhou et al. JOURNAL OF DRUG TARGETING
- Biophysical and Ultrastructural Characterization of Adeno-Associated Virus Capsid Uncoating and Genome Release
- (2012) E. D. Horowitz et al. JOURNAL OF VIROLOGY
- Patterns of scAAV Vector Insertion Associated With Oncogenic Events in a Mouse Model for Genotoxicity
- (2012) Lucia E Rosas et al. MOLECULAR THERAPY
- The Spinal Cord
- (2012) Orhan Bican et al. NEUROLOGIC CLINICS
- LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease
- (2012) Carlos Spuch et al. Frontiers in Physiology
- Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors
- (2011) Noriko Miyake et al. BRAIN RESEARCH
- Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
- (2011) Lluis Samaranch et al. HUMAN GENE THERAPY
- Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
- (2011) Yasuo Uchida et al. JOURNAL OF NEUROCHEMISTRY
- Quantitative Targeted Absolute Proteomics-Based Adme Research as A New Path to Drug Discovery and Development: Methodology, Advantages, Strategy, and Prospects
- (2011) Sumio Ohtsuki et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
- (2011) Ramzi Shawahna et al. MOLECULAR PHARMACEUTICS
- Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
- (2011) Steven J Gray et al. MOLECULAR THERAPY
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid- Production in Vivo
- (2011) J. K. Atwal et al. Science Translational Medicine
- Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model
- (2010) I. Visigalli et al. BLOOD
- Brain-Penetrating Tumor Necrosis Factor Decoy Receptor in the Mouse
- (2010) Q.-H. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein
- (2010) Ruben J. Boado et al. JOURNAL OF BIOTECHNOLOGY
- Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
- (2010) R. J. Boado et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Re-Engineering Erythropoietin as an IgG Fusion Protein That Penetrates the Blood−Brain Barrier in the Mouse
- (2010) Qing-Hui Zhou et al. MOLECULAR PHARMACEUTICS
- Vascular pathology in Alzheimer's disease
- (2010) Taihei MIYAKAWA Psychogeriatrics
- Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin Receptor
- (2009) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study
- (2009) John M. Starr et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse
- (2008) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-β peptide in a blood–brain barrier in vitro model
- (2008) Babak Nazer et al. NEUROBIOLOGY OF DISEASE
- Near Complete Rescue of Experimental Parkinson’s Disease with Intravenous, Non-viral GDNF Gene Therapy
- (2008) Yun Zhang et al. PHARMACEUTICAL RESEARCH
- A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier
- (2008) Delara Karkan et al. PLoS One
- GDNF fusion protein for targeted-drug delivery across the human blood–brain barrier
- (2007) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now